Postoperative subjective pain reports measured by VAS scores by patients undergoing DIEP flaps for breast reconstruction were significantly improved with the use of intraoperative Exparel. In addition, there was a statistically significant decreased HLOS and lower rate of PCA use in the cohort that received Exparel.
METHODS:
Patients presenting to clinic for initial evaluation for lymphedema surgery since January 2017 were offered to complete a survey designed to evaluate their expectations for limb appearance, limb function, and overall well-being following lymphedema surgery. The patients were instructed to score each item utilizing a 5-point scale for improvement (5-complete; 4-significant; 3-moderate; 2-mild; 1-no improvement) . No score was given if the patient answered "does not apply" to a question or left it blank. A mean total expectation score was calculated, which was then used to estimate the effects of pre-operative variables on patient expectations using multiple regression analysis.
RESULTS:
A total of 21 females and 2 males completed the survey with a mean age of 60 (36-80, SD 13.5) years. The upper limbs were affected in 10 and lower limbs in 13 patients. Physicians were the initial source of information about lymphedema surgery as a potential treatment option in 10 patients (43%), whereas 8 (34.8 %) patients initially learned about lymphedema surgery from non-physician health care professionals, 1 (4.3 %) from family/friends, and 4 (17.4 %) from the internet. Based on prior experience with non-lymphedema specialist physicians, only four (17.3 %) patients believed physicians had excellent or good knowledge about the utility of lymphedema surgery as a treatment strategy, whereas two (8.7 %) thought they had fair knowledge, and 13 (56.5 %) thought they had poor knowledge. The mean expectation score for improvement in limb appearance was 3.7 (2.5 -5.0, SD 0.77), limb function 3.5 (1.0 -5.0, SD 1.3) and overall well-being 3.4 (1.5 -5.0, SD 1.02). The mean total expectation score following lymphedema surgery was 3.5 (2.0 -5.0, SD 0.85). Multiple regression analysis showed that the patients' level of education (p -0.045), disease duration (p -0.027) and the method of first learning about lymphedema surgery (p -0.038) had a statistically significant impact on the patients' expectation for lymphedema surgery. The total mean expectation score was inversely related to the patient's level of education and learning about lymphedema surgery from non-physicians. Additionally, disease duration had direct relationship with the patient's total mean expectation score.
CONCLUSIONS:
Early data suggest that most patients learn about lymphedema surgery from non-physicians late in their disease course with many expecting complete or significant improvement of lymphedema-associated symptoms with surgery. It appears that the level of patient education, source of information and disease duration may impact patient expectations. Most patients also believed that nonlymphedema specialist physicians had fair or poor knowledge about lymphedema surgery as a treatment strategy for lymphedema. These findings raise a concern for possible patients' unrealistic expectations for lymphedema surgery which may be in part due to the lack of knowledge among physicians about surgical treatment options of lymphedema. with an option for post-mastectomy breast reconstruction alternative to simple mastectomy without reconstruction, complex autologous flap harvesting techniques, or the use of artificial implants. The purpose of this study was to provide outcomes data for 172 Goldilocks mastectomy procedures performed at a single tertiary academic center analyzing complication rate, relevant comorbidities, and adjuvant cancer treatment impacting functional and aesthetic outcomes. This is the largest series of Goldilocks mastectomy procedures to be reported to date.
METHODS:
Relevant comorbidities and complication data were collected. Patients who had prior surgical procedures before presenting to our institution were designated as such. Specific breast cancer pathology and previous breast therapy were indicated. Data relevant to the Goldilocks reconstruction at our institution were collected, including laterality of procedure(s), indication (i.e. prophylactic or therapeutic), whether a tissue expander or an implant was placed at the time of the Goldilocks procedure or at any point following the procedure, the number of procedures needed for the entire reconstructive regimen, and any specific revision procedures, if needed (i.e. fat grafting, mastopexy, augmentation, or scar revision).
RESULTS:
A total of 95 patients underwent reconstruction with Goldilocks procedure. 82.1% (78) of cases were bilateral, and 17.8% (17) were unilateral reconstructions. Breast cancer pathology results included: DCIS 27.3% (26), LCIS 5.26% (5), stage I 11.57 (11), stage II 23.1% (22), stage III 23.1% (22), inflammatory 5.3% (5), BRCA prophylactic 11.5% (11), other 2.1% (2), and recurrent cancer 6.3% (6). Pre-operative radiation therapy was given in 7.4% (7) of patients, while post-operative radiation therapy was given to 6.31% (6) of patients. 22.1% (21) of patients received chemotherapy and 17.8% (17) received hormone therapy. Previous breast reconstruction history included implantbased reconstruction in 3.15% (3), autologous 1% (1), multiple attempts 1% (1), and failed reconstruction 1% (1). Reconstruction types included Goldilocks-only in 58% (53) of patients, Goldilocks + tissue expander in 35.8% (34), and Goldilocks with implant in 10.5% (10). 45.3% (43) of patients underwent adjuvant fat grafting, 7.3% (7) underwent concurrent mastopexy, 5.2% (5) underwent concurrent breast augmentation, and 14.7% (14) had scar revision procedures performed at the time of Goldilocks procedure. Complications included: seroma 6.3% (6), hematoma 4.2% (4), cellulitis 4.2% (4), wound dehiscence 4.2% (4), DVT/ PE 1% (1), readmission 1% (1), needed take back to OR 9.5% (9), needed explant 7.4 %(7), or other complications 3.1% (3).
CONCLUSION:
Goldilocks mastectomy procedures are a useful adjunct in reconstruction, and can also be used in implant-based reconstruction, providing a dermal sling to build an internal bra and scaffold for the implant. Patients who have relevant medical comorbidities or who decline traditional methods of reconstruction can greatly benefit from Goldilocks mastectomy. There may be substantial utility in considering Goldilocks procedures during pre-operative planning in patient-centered care along the reconstructive ladder, as this approach has the ability of being modified with additional procedures such as fat grafting or implant placement.
